Gyre Therapeutics, Inc. (GYRE) earnings
GYRE earnings moved a median of -1.57% by the close. Quarterly and annual GYRE reports and results, each read against the price at its own news timestamp. Back to the GYRE overview →
19 measured GYRE earnings events.
Where these GYRE earnings landedvs 16 measured GYRE earnings reactions
| Middle 50% of GYRE earnings reactions | -5.74% to +0.57% |
|---|---|
| Median reaction (to close) | -1.57% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 GYRE earnings events with a measured close landed between -5.74% and +0.57%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q GYRE THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.75% | — | |
| Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update | Press release | +1.56% | +4.06% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.47% | -4.19% | |
| Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update | Press release | -7.04% | -10.51% | |
| Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | -0.91% | -2.09% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.18% | +3.80% | |
| Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update | Press release | -1.65% | -0.82% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.07% | — | |
| Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update | Press release | +0.07% | — | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +3.28% | +14.36% | |
| Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +3.28% | +7.80% | |
| Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | -18.00% | -25.48% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.35% | -4.22% | |
| Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update | Press release | +1.42% | -6.88% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | -4.89% | -7.42% | |
| Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update | Press release | +1.90% | -1.05% | |
| Form 10-Q GYRE THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.47% | -0.51% | |
| Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | -5.36% | |
| Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.57% |
Keep exploring
More GYRE: analyst actions → · SEC filings → · GYRE overview →